The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Th17 Cells in Cancer: The Ultimate Identity Crisis
Open accessAbstract
T helper 17 (Th17) cells play a complex and controversial role in tumor immunity and have been found to exhibit a fluctuating identity within the context of cancer. The recent, expanding literature on these cells attests to their puzzling nature, either promoting or suppressing tumor growth depending on the malignancy and course of therapeutic intervention investigated. This review addresses several newly appreciated factors that may help delineate Th17 cells' immunological properties in the context of cancer. Several reports suggest that inflammatory signals induced in the tumor milieu regulate the functional fate and antitumor activity of Th17 cells. Recent findings also point to significant alterations in Th17 cells due to their interplay with regulatory T lymphocytes and cytotoxic CD8(+) T cells within the tumor microenvironment. Finally, an appreciation for the stem cell-like properties of Th17 cells that augment their persistence and activity emerges from recent reports. The impact of these factors on Th17 cells' antitumor efficacy and how these factors may be exploited to improve cancer therapies will be discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Natural and inducible TH17 cells are regulated differently by Akt and mTOR pathways
Kim, J. S., Sklarz, T., Banks, L. B., Gohil, M., Waickman, A. T., Skuli, N., Krock, B. L., Luo, C. T., Hu, W., Pollizzi, K. N., et al. (2013) · Nature Immunology · doi:10.1038/ni.2607 · Cited by 85
RetractedCoussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Mosmann, T. R., & Coffman, R. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.001045 · Cited by 7,692
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873
Chimeric antigen receptor–modified T cells in chronic lymphoid leukemia
Porter, D. L., Levine, B. L., Kalos, M., Bagg, A., & June, C. H. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103849 · Cited by 3,565
Differentiation of Effector CD4 T Cell Populations
Zhu, J., Yamane, H., & Paul, W. E. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101212 · Cited by 3,452
Regulatory T cells: mechanisms of differentiation and function
Josefowicz, S. Z., Lu, L.-F., & Rudensky, A. Y. (2012) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141623 · Cited by 2,866
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Liu, W., Putnam, A. L., Xu-yu, Z., Szot, G. L., Lee, M. R., Zhu, S., Gottlieb, P. A., Kapranov, P., Gingeras, T. R., de St. Groth, B. F., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060772 · Cited by 2,606
Kalos, M., Levine, B. L., Porter, D. L., Katz, S., Grupp, S. A., Bagg, A., & June, C. H. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002842 · Cited by 2,388
Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
Albert, M. L., Sauter, B., & Bhardwaj, N. (1998) · Nature · doi:10.1038/32183 · Cited by 2,349
Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330
Drug delivery with carbon nanotubes for in vivo cancer treatment
Liu, Z., Chen, K., Davis, C. R., Sherlock, S. P., Cao, Q., Chen, X. S., & Dai, H. (2008) · PubMed · doi:10.48550/arxiv.0808.2070 · Cited by 2,286
Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor
Quintana, F. J., Basso, A. S., Iglesias, A. H., Korn, T., Farez, M. F., Bettelli, E., Caccamo, M., Oukka, M., & Weiner, H. L. (2008) · Nature · doi:10.1038/nature06880 · Cited by 1,865
Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells
Acosta-Rodriguez, E. V., Rivino, L., Geginat, J., Jarrossay, D., Gattorno, M., Lanzavecchia, A., Sallusto, F., & Napolitani, G. (2007) · Nature Immunology · doi:10.1038/ni1467 · Cited by 1,828
Wu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.-R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2015 · Cited by 1,812
CD4 T cells: fates, functions, and faults
Zhu, J., & Paul, W. E. (2008) · Blood · doi:10.1182/blood-2008-05-078154 · Cited by 1,798
Adoptive immunotherapy for cancer: harnessing the T cell response
Restifo, N. P., Dudley, M. E., & Rosenberg, S. A. (2012) · Nature Reviews Immunology · doi:10.1038/nri3191 · Cited by 1,688
The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins
Veldhoen, M., Hirota, K., Westendorf, A. M., Buer, J., Dumoutier, L., Renauld, J.-C., & Stockinger, B. (2008) · Nature · doi:10.1038/nature06881 · Cited by 1,634
Robbins, P. F., Morgan, R. A., Feldman, S. A., Yang, J. C., Sherry, R. M., Dudley, M. E., Wunderlich, J. R., Nahvi, A. V., Helman, L. J., Mackall, C. L., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.2537 · Cited by 1,632
McGeachy, M. J., Bak-Jensen, K. S., Chen, Y., Tato, C. M., Blumenschein, W., McClanahan, T., & Cua, D. J. (2007) · Nature Immunology · doi:10.1038/ni1539 · Cited by 1,520
Th17: An Effector CD4 T Cell Lineage with Regulatory T Cell Ties
Weaver, C. T., Harrington, L. E., Mangan, P. R., Gavrieli, M., & Murphy, K. M. (2006) · Immunity · doi:10.1016/j.immuni.2006.06.002 · Cited by 1,422 · cited 1×
“, plasticity; Figure 3) (97, 98); two, Th17 cells release immunosuppressive adenosine upon TGF-β-dependent ectonucleotidase expression (99) as illustrated in Figure 4 and described in detail below.”
BackgroundGeneration of pathogenic TH17 cells in the absence of TGF-β signalling
Ghoreschi, K., Laurence, A., Yang, X.-P., Tato, C. M., McGeachy, M. J., Konkel, J. E., Ramos, H. L., Wei, L., Davidson, T. S., Bouladoux, N., et al. (2010) · Nature · doi:10.1038/nature09447 · Cited by 1,388
Steinman, L. (2007) · Nature Medicine · doi:10.1038/nm1551 · Cited by 1,376
Milone, M. C., Fish, J. D., Carpenito, C., Carroll, R. G., Binder, G. K., Teachey, D., Samanta, M., Lakhal, M., Gloss, B., Danet-Desnoyers, G., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2009.83 · Cited by 1,197
Induction and molecular signature of pathogenic TH17 cells
Lee, Y., Awasthi, A., Yosef, N., Quintana, F. J., Xiao, S., Peters, A., Wu, C., Kleinewietfeld, M., Kunder, S., Hafler, D. A., et al. (2012) · Nature Immunology · doi:10.1038/ni.2416 · Cited by 1,174
A Validated Regulatory Network for Th17 Cell Specification
Ciofani, M., Madar, A., Galan, C., Sellars, M., Mace, K., Pauli, F., Agarwal, A., Huang, W., Parkurst, C. N., Muratet, M., et al. (2012) · Cell · doi:10.1016/j.cell.2012.09.016 · Cited by 1,160
Tosolini, M., Kirilovsky, A., Mlecnik, B., Fredriksen, T., Mauger, S., Bindea, G., Berger, A., Bruneval, P., Fridman, W.-H., Pagès, F., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2907 · Cited by 1,146
Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease.
Kidd, P. M. (2003) · PubMed · Cited by 1,102
TH17 cells in development: an updated view of their molecular identity and genetic programming
Dong, C. (2008) · Nature reviews. Immunology · doi:10.1038/nri2295 · Cited by 1,064
Late Developmental Plasticity in the T Helper 17 Lineage
Lee, Y. K., Turner, H., Maynard, C. L., Oliver, J. R., Chen, D., Elson, C. O., & Weaver, C. T. (2009) · Immunity · doi:10.1016/j.immuni.2008.11.005 · Cited by 1,053
Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells
Gattinoni, L., Zhong, X.-S., Palmer, D. C., Ji, Y., Hinrichs, C. S., Yu, Z., Wrzesinski, C., Boni, A., Cassard, L., Garvin, L. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1982 · Cited by 1,031
Self-citationInduction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1
Wu, C., Yosef, N., Thalhamer, T., Zhu, C., Xiao, S., Kishi, Y., Regev, A., & Kuchroo, V. K. (2013) · Nature · doi:10.1038/nature11984 · Cited by 1,022
Gattinoni, L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24480 · Cited by 958
Innate Immunity Gone Awry: Linking Microbial Infections to Chronic Inflammation and Cancer
Karin, M., Lawrence, T., & Nizet, V. (2006) · Cell · doi:10.1016/j.cell.2006.02.016 · Cited by 942
Th17 and regulatory T cell balance in autoimmune and inflammatory diseases
Noack, M., & Miossec, P. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.12.004 · Cited by 932
Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β
Zielinski, C. E., Mele, F., Aschenbrenner, D., Jarrossay, D., Ronchi, F., Gattorno, M., Monticelli, S., Lanzavecchia, A., & Sallusto, F. (2012) · Nature · doi:10.1038/nature10957 · Cited by 919
Tumor-specific Th17-polarized cells eradicate large established melanoma
Muranski, P., Boni, A., Antony, P. A., Cassard, L., Irvine, K. R., Kaiser, A., Paulos, C. M., Palmer, D. C., Touloukian, C. E., Ptak, K., et al. (2008) · Blood · doi:10.1182/blood-2007-11-120998 · Cited by 845
Self-citationAdoptive immunotherapy for cancer: building on success
Gattinoni, L., Powell, D. J., Rosenberg, S. A., & Restifo, N. P. (2006) · Nature Reviews Immunology · doi:10.1038/nri1842 · Cited by 845
Interleukin-17 promotes angiogenesis and tumor growth
Numasaki, M. (2003) · Blood · doi:10.1182/blood-2002-05-1461 · Cited by 834
Kryczek, I., Banerjee, M., Cheng, P., Vatan, L., Szeliga, W., Wei, S., Huang, E., Finlayson, E., Simeone, D., Welling, T. H., et al. (2009) · Blood · doi:10.1182/blood-2009-03-208249 · Cited by 813
T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor Immunity
Martin-Orozco, N., Muranski, P., Chung, Y., Yang, X. O., Yamazaki, T., Lu, S., Hwu, P., Restifo, N. P., Overwijk, W. W., & Dong, C. (2009) · Immunity · doi:10.1016/j.immuni.2009.09.014 · Cited by 800
Human CD25highFoxp3pos regulatory T cells differentiate into IL-17–producing cells
Koenen, H. J. P. M., Smeets, R. L., Vink, P. M., van Rijssen, E., Boots, A. M. H., & Joosten, I. (2008) · Blood · doi:10.1182/blood-2008-01-133967 · Cited by 736
EGFR-TKI resistance due to BIM polymorphism can be circumvented in combination with HDAC inhibition
中川, 学. (2014) · Institutional Repositories DataBase (IRDB) · Cited by 736
Human interleukin 17–producing cells originate from a CD161+CD4+ T cell precursor
Cosmi, L., De Palma, R., Santarlasci, V., Maggi, L., Capone, M., Frosali, F., Rodolico, G., Querci, V., Abbate, G., Angeli, R., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080397 · Cited by 706
DeNardo, D. G., & Coussens, L. M. (2007) · Breast Cancer Research · doi:10.1186/bcr1746 · Cited by 677
Circulating Th17, Th22, and Th1 Cells Are Increased in Psoriasis
Kagami, S., Rizzo, H. L., Lee, J. J., Koguchi, Y., & Blauvelt, A. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.399 · Cited by 640
TH17 cells in tumour immunity and immunotherapy
Zou, W., & Restifo, N. P. (2010) · Nature Reviews Immunology · doi:10.1038/nri2742 · Cited by 624
Paulos, C. M., Wrzesinski, C., Kaiser, Hinrichs, C. S., Chieppa, M., Cassard, L., Palmer, D. C., Boni, A., Muranski, P., Yu, Z., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32205 · Cited by 586 · cited 1×
“Interestingly, however, gut microbes perturbed by lymphodepletion/chemotherapy, a phenomenon called microbial translocation, improve adoptive CD8 T cell immunotherapies for melanoma (62).”
BackgroundSelf-citationAdoptive T cell therapy for cancer in the clinic
June, C. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32446 · Cited by 553
Concomitant Tumor Immunity to a Poorly Immunogenic Melanoma Is Prevented by Regulatory T Cells
Turk, M. J., Guevara-Patiño, J. A., Rizzuto, G. A., Engelhorn, M. E., & Houghton, A. N. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041130 · Cited by 540
Zhang, J.-P., Yan, J., Xu, J., Pang, X.-H., Chen, M.-S., Li, L., Wu, C., Li, S.-P., & Zheng, L. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.12.033 · Cited by 535
Veldhoen, M., Hirota, K., Christensen, J., O'Garra, A., & Stockinger, B. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081438 · Cited by 520
Transcriptional regulation of Th17 cell differentiation
Ivanov, I. I., Zhou, L., & Littman, D. R. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.10.011 · Cited by 484
Naive tumor-specific CD4+ T cells differentiated in vivo eradicate established melanoma
Xie, Y., Akpinarli, A., Maris, C., Hipkiss, E. L., Lane, M., Kwon, E.-K. M., Muranski, P., Restifo, N. P., & Antony, P. A. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091921 · Cited by 457
Zhao, Y., Moon, E., Carpenito, C., Paulos, C. M., Liu, X., Brennan, A. L., Chew, A., Carroll, R. G., Scholler, J., Levine, B. L., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2880 · Cited by 450
Self-citationTh17 cells are long lived and retain a stem cell-like molecular signature
Muranski, P., Borman, Z. A., Kerkar, S. P., Klebanoff, C. A., Ji, Y., Sanchez-Perez, L., Sukumar, M., Reger, R. N., Yu, Z., Kern, S. J., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.019 · Cited by 443
IL-23 Promotes Maintenance but Not Commitment to the Th17 Lineage
Stritesky, G. L., Yeh, N., & Kaplan, M. H. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.5948 · Cited by 417
Humoral immunity, inflammation and cancer
Tan, T.-T., & Coussens, L. M. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.01.001 · Cited by 417
Kryczek, I., Wei, S., Zou, L., Altuwaijri, S., Szeliga, W., Kolls, J., Chang, A., & Zou, W. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.6730 · Cited by 416
BACH2 represses effector programs to stabilize Treg-mediated immune homeostasis
Roychoudhuri, R., Hirahara, K., Mousavi, K., Clever, D., Klebanoff, C. A., Bonelli, M., Sciumè, G., Zare, H., Vahedi, G., Dema, B., et al. (2013) · Nature · doi:10.1038/nature12199 · Cited by 407
Endogenous IL-17 contributes to reduced tumor growth and metastasis
Kryczek, I., Wei, S., Szeliga, W., Vatan, L., & Zou, W. (2009) · Blood · doi:10.1182/blood-2008-09-177360 · Cited by 403
Mandapathil, M., Hilldorfer, B., Szczepanski, M. J., Czystowska, M., Szajnik, M., Ren, J., Lang, S., Jackson, E. K., Gorelik, E., & Whiteside, T. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.047423 · Cited by 390
Bremnes, R. M., Al-Shibli, K., Donnem, T., Sirera, R., Al-Saad, S., Andersen, S., Stenvold, H., Camps, C., & Busund, L.-T. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182037b76 · Cited by 369
Jochems, C., & Schlom, J. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.011007 · Cited by 353
Chalmin, F., Mignot, G., Bruchard, M., Chevriaux, A., Végran, F., Hichami, A., Ladoire, S., Derangère, V., Vincent, J., Masson, D., et al. (2012) · Immunity · doi:10.1016/j.immuni.2011.12.019 · Cited by 338
T helper 17 cells play a critical pathogenic role in lung cancer
Chang, S. H., Mirabolfathinejad, S. G., Katta, H., Cumpian, A. M., Gong, L., Caetano, M. S., Moghaddam, S. J., & Dong, C. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319051111 · Cited by 326 · cited 2×
“showed that the production of IL-17 by Th17 cells in the mouse lung cancer model K-ras (G12D) was sufficient to drive tumor growth through the recruitment of myeloid suppressor cells (88).”
BackgroundCancer and Inflammation: Promise for Biologic Therapy
Demaria, S., Pikarsky, E., Karin, M., Coussens, L. M., Chen, Y.-C., El-Omar, E. M., Trinchieri, G., Dubinett, S. M., Mao, J. T., Szabo, E., et al. (2010) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181d32e74 · Cited by 325
Tumor microenvironments direct the recruitment and expansion of human Th17 cells
Su, X., Ye, J., Hsueh, E. C., Zhang, Y., Hoft, D. F., & Peng, G. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902813 · Cited by 324
Monoclonal TCR-redirected tumor cell killing
Liddy, N., Bossi, G., Adams, K. J., Lissina, A., Mahon, T. M., Hassan, N. J., Gavarret, J., Bianchi, F. C., Pumphrey, N. J., Ladell, K., et al. (2012) · Nature Medicine · doi:10.1038/nm.2764 · Cited by 324
The transcriptional programme of antibody class switching involves the repressor Bach2
Muto, A., Tashiro, S., Nakajima, O., Hoshino, H., Takahashi, S., Sakoda, E., Ikebe, D., Yamamoto, M., & Igarashi, K. (2004) · Nature · doi:10.1038/nature02596 · Cited by 292
A novel heterodimeric cytokine consisting of IL-17 and IL-17F regulates inflammatory responses
Chang, S. H., & Dong, C. (2007) · Cell Research · doi:10.1038/cr.2007.35 · Cited by 280
Human T H 17 Cells Are Long-Lived Effector Memory Cells
Kryczek, I., Zhao, E., Liu, Y., Wang, Y., Vatan, L., Szeliga, W., Moyer, J., Klimczak, A., Lange, A., & Zou, W. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002949 · Cited by 278
Kuang, D.-M., Peng, C., Zhao, Q., Wu, Y., Chen, M.-S., & Zheng, L. (2010) · Hepatology · doi:10.1002/hep.23291 · Cited by 263
The Inducible Costimulator (ICOS) Is Critical for the Development of Human T H 17 Cells
Paulos, C. M., Carpenito, C., Plesa, G., Suhoski, M. M., Varela-Rohena, A., Golovina, T. N., Carroll, R. G., Riley, J. L., & June, C. H. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000448 · Cited by 255
Self-citationIsoform-Specific Inhibition of RORα-Mediated Transcriptional Activation by Human FOXP3
Du, J., Huang, C., Zhou, B., & Ziegler, S. F. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4785 · Cited by 233
Adoptive immunotherapy of cancer using CD4+ T cells
Muranski, P., & Restifo, N. P. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.02.004 · Cited by 220
Tai, X., Erman, B., Alag, A., Mu, J., Kimura, M., Katz, G., Guinter, T., McCaughtry, T., Etzensperger, R., Feigenbaum, L., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.02.022 · Cited by 218
Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients
Chen, X., Wan, J., Liu, J., Xie, W., Diao, X., Xu, J., Zhu, B., & Chen, Z. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2009.11.013 · Cited by 217
Dhodapkar, K. M., Barbuto, S., Matthews, P., Kukreja, A., Mazumder, A., Vesole, D., Jagannath, S., & Dhodapkar, M. V. (2008) · Blood · doi:10.1182/blood-2008-03-143222 · Cited by 216
Chen, D.-Y., Chen, Y.-M., Chen, H.-H., Hsieh, C.-W., Lin, C.-C., & Lan, J.-L. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3431 · Cited by 216
Wang, Y., Godec, J., Ben-Aissa, K., Cui, K., Zhao, K., Pucsek, A. B., Lee, Y. K., Weaver, C. T., Yagi, R., & Lazarevic, V. (2014) · Immunity · doi:10.1016/j.immuni.2014.01.002 · Cited by 207
CD4+CD25+ T Regulatory Cells, Immunotherapy of Cancer, and Interleukin-2
Antony, P. A., & Restifo, N. P. (2005) · Journal of Immunotherapy · doi:10.1097/01.cji.0000155049.26787.45 · Cited by 205
Inflammation and colorectal cancer, when microbiota-host mutualism breaks
Candela, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i4.908 · Cited by 197
CTLA4 blockade increases Th17 cells in patients with metastatic melanoma
von Euw, E., Chodon, T., Attar, N., Jalil, J., Koya, R. C., Comin-Anduix, B., & Ribas, A. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-35 · Cited by 189
IL-17 Enhances Tumor Development in Carcinogen-Induced Skin Cancer
Wang, L., Yi, T., Zhang, W., Pardoll, D. M., & Yu, H. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0775 · Cited by 185
Gomez-Rodriguez, J., Wohlfert, E. A., Handon, R., Meylan, F., Wu, J. Z., Anderson, S. M., Kirby, M. R., Belkaid, Y., & Schwartzberg, P. L. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20131459 · Cited by 180
Inflammation, proteases and cancer
van Kempen, L. C. L., de Visser, K. E., & Coussens, L. M. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.004 · Cited by 177
Lança, T., & Silva‐Santos, B. (2012) · OncoImmunology · doi:10.4161/onci.20068 · Cited by 174
Human Th17 Cells Express High Levels of Enzymatically Active Dipeptidylpeptidase IV (CD26)
Bengsch, B., Seigel, B., Flecken, T., Wolanski, J., Blum, H. E., & Thimme, R. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103801 · Cited by 169
Maruyama, T., Kono, K., Mizukami, Y., Kawaguchi, Y., Mimura, K., Watanabe, M., Izawa, S., & Fujii, H. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01624.x · Cited by 163
Keerthivasan, S., Aghajani, K., Dose, M., Molinero, L., Khan, M. W., Venkateswaran, V., Weber, C., Emmanuel, A. O., Sun, T., Bentrem, D. J., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007607 · Cited by 161
Valmori, D., Raffin, C., Raimbaud, I., & Ayyoub, M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008247107 · Cited by 160
Yang, Z., Novak, A. J., Ziesmer, S. C., Witzig, T. E., & Ansell, S. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0266 · Cited by 160
Pinato, D. J., Shiner, R. J., Seckl, M. J., Stebbing, J., Sharma, R., & Mauri, F. A. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.145 · Cited by 157
Rácz, E., Prens, E. P., Kurek, D., Kant, M., de Ridder, D., Mourits, S., Baerveldt, E. M., Özgür, Z., van IJcken, W. F. J., Laman, J. D., et al. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.53 · Cited by 156
A Protective Role by Interleukin-17F in Colon Tumorigenesis
Tong, Z., Yang, X. O., Yan, H., Liu, W., Niu, X., Shi, Y., Fang, W., Xiong, B., Wan, Y., & Dong, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034959 · Cited by 155
Different subsets of tumor infiltrating lymphocytes correlate with NPC progression in different ways
Zhang, Y.-L., Li, J., Mo, H., Qiu, F., Zheng, L., Qian, C.-N., & Zeng, Y.-X. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-4 · Cited by 155
Chen, Y., Haines, C. J., Gutcher, I., Hochweller, K., Blumenschein, W. M., McClanahan, T., Hämmerling, G., Li, M. O., Cua, D. J., & McGeachy, M. J. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.011 · Cited by 123
Baumgart, S., Chen, N., Siveke, J. T., König, A. O., Zhang, J., Singh, S. K., Wolf, E., Bartkuhn, M., Esposito, I., Heßmann, E., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0593 · Cited by 123
Derhovanessian, E., Adams, V., Hähnel, K., Groeger, A., Pandha, H., Ward, S., & Pawelec, G. (2009) · International Journal of Cancer · doi:10.1002/ijc.24497 · Cited by 122
Stat3 Activation in Murine Colitis Induced by Enterotoxigenic Bacteroides fragilis
Wick, E. C., Rabizadeh, S., Albesiano, E., Wu, X., Wu, S., Chan, J. L., Rhee, K., Ortega, G., Huso, D. L., Pardoll, D. M., et al. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000019 · Cited by 115
Munegowda, M. A., Deng, Y., Mulligan, S. J., & Xiang, J. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1054-y · Cited by 114
Connor, K. T., & Aylward, L. L. (2006) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/15287390500196487 · Cited by 113
Furuhashi, T., Saito, C., Torii, K., Nishida, E., Yamazaki, S., & Morita, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054895 · Cited by 109
Horlock, C., Stott, B., Dyson, P. J., Morishita, M., Coombes, R. C., Savage, P. M., & Stebbing, J. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604963 · Cited by 108
Fialová, A., Partlová, S., Sojka, L., Hromádková, H., Brtnický, T., Fucikova, J. P., Kocián, P., Rob, L., Bartůňková, J., & Špíšek, R. (2012) · International Journal of Cancer · doi:10.1002/ijc.27759 · Cited by 108
IL-17 Mediated Inflammation Promotes Tumor Growth and Progression in the Skin
He, D., Li, H., Yusuf, N., Elmets, C. A., Athar, M., Katiyar, S. K., & Xu, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032126 · Cited by 105
Controversies on the role of Th17 in cancer: a TGF-β-dependent immunosuppressive activity?
Martin, F., Apétoh, L., & Ghiringhelli, F. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.09.007 · Cited by 104
FoxP3+RORγt+ T Helper Intermediates Display Suppressive Function against Autoimmune Diabetes
Tartar, D. M., VanMorlan, A. M., Wan, X., Guloglu, F. B., JAIN, R. K., Haymaker, C., Ellis, J. S., Hoeman, C. M., Cascio, J. A., Dhakal, M., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903324 · Cited by 99
Kesselring, R., Thiel, A., Pries, R., Trenkle, T., & Wollenberg, B. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605891 · Cited by 98
Weber, G. F., Gaertner, F. C., Erl, W., Janssen, K., Blechert, B., Holzmann, B., Weighardt, H., & Essler, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.8266 · Cited by 85
Lo, Y., Torii, K., Saito, C., Furuhashi, T., Maeda, A., & Morita, A. (2010) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2010.03.018 · Cited by 82
Genetic engineering of T cells for adoptive immunotherapy
Varela‐Rohena, A., Carpenito, C., Pérez, E., Richardson, M. W., Parry, R. V., Milone, M. C., Scholler, J., Hao, X., Mexas, A. M., Carroll, R. G., et al. (2008) · Immunologic Research · doi:10.1007/s12026-008-8057-6 · Cited by 80
Embelin Reduces Colitis-Associated Tumorigenesis through Limiting IL-6/STAT3 Signaling
Dai, Y., Jiao, H., Teng, G., Wang, W., Zhang, R., Wang, Y., Hebbard, L., George, J., & Qiao, L. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0378 · Cited by 80
Senescence-associated SIN3B promotes inflammation and pancreatic cancer progression
Rielland, M., Cantor, D. J., Graveline, R., Hajdu, C., Mara, L., de Diego Diaz, B., Miller, G., & David, G. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72619 · Cited by 76 · cited 1×
“Th17 CELL-MEDIATED INFLAMMATION IN CANCER Inflammation has long been recognized as a mediator of tumor progression in diseases such as colorectal (80), pancreatic (81, 82), and lung (83) cancer.”
BackgroundJain, P., Javdan, M., Feger, F., Chiu, P., Sison, C., Damle, R. N., Bhuiya, T., Şen, F., Abruzzo, L. V., Burger, J. A., et al. (2011) · Haematologica · doi:10.3324/haematol.2011.047316 · Cited by 75
Kobold, S., Völk, S., Clauditz, T. S., Küpper, N. J., Minner, S. J. P., Tufman, A., Duewell, P., Lindner, M., Koch, I., Heidegger, S. M., et al. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31829923c8 · Cited by 69
Zhao, Y., Yang, L., Wang, X., & Zhou, Z. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2530 · Cited by 65
Angiostatic activity of the antitumor cytokine interleukin-21
Castermans, K., Tabruyn, S. P., Zeng, R., B, J. R. V. B., Eppolito, C., Leonard, W. J., Shrikant, P. A., & Griffioen, A. W. (2008) · Blood · doi:10.1182/blood-2007-09-113878 · Cited by 64
Erratum: TH17 cells in tumour immunity and immunotherapy
Zou, W., & Restifo, N. P. (2011) · Nature reviews. Immunology · doi:10.1038/nri3029 · Cited by 60
Th17 cell expansion in gastric cancer may contribute to cancer development and metastasis
Su, Z., Sun, Y., Zhu, H., Liu, Y., Lin, X., Shen, H., Chen, J., Xu, W., & Xu, H. (2014) · Immunologic Research · doi:10.1007/s12026-013-8483-y · Cited by 53
Rizzo, A., Mare, V. D., Rocchi, C., Stolfi, C., Colantoni, A., Neurath, M. F., MacDonald, T. T., Pallone, F., Monteleone, G., & Fantini, M. C. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu027 · Cited by 47
Adoptive immunotherapy: good habits instilled at youth have long-term benefits
Paulos, C. M., Suhoski, M. M., Plesa, G., Jiang, T., Basu, S., Golovina, T. N., Jiang, S., Aqui, N. A., Powell, D. J., Levine, B. L., et al. (2008) · Immunologic Research · doi:10.1007/s12026-008-8070-9 · Cited by 44
Self-citationEkman, A., Sigurdardottir, G., Carlström, M., Kartul, N., Jenmalm, M. C., & Enerbäck, C. (2013) · Acta Dermato Venereologica · doi:10.2340/00015555-1545 · Cited by 43
Sawada, Y., Nakamura, M., Kabashima‐Kubo, R., Shimauchi, T., Kobayashi, M., & TOKURA, Y. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0292 · Cited by 41
Yu, Y., Iclozan, C., Yamazaki, T., Yang, X. O., Anasetti, C., Dong, C., & Yu, X. (2009) · Blood · doi:10.1182/blood-2009-03-210153 · Cited by 37
Wang, W., Edington, H. D. J., Rao, U. N. M., Jukic, D. M., Radfar, A., Wang, H., & Kirkwood, J. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0705 · Cited by 37
Embelin suppresses pancreatic cancer growth by modulating tumor immune microenvironment
Marsh, J. (2014) · Frontiers in bioscience · doi:10.2741/4198 · Cited by 35
The Role of T-Helper 17 (Th17) Cells in Patients with Medulloblastoma
Zhou, P., Sha, H., & Zhu, J. (2010) · Journal of International Medical Research · doi:10.1177/147323001003800223 · Cited by 30
Th17 related cytokines in acute myeloid leukemia
Li, P., Ji, M., Park, J., Bunting, K. D., Ji, C., & Tse, W. (2012) · Frontiers in bioscience · doi:10.2741/4052 · Cited by 29
Munn, D. H. (2009) · Blood · doi:10.1182/blood-2009-06-224246 · Cited by 28
Increased Th22 cells are independently associated with Th17 cells in type 1 diabetes
Xu, X., Zheng, S., Yang, F., Shi, Y., Gu, Y., Chen, H., Zhang, M., & Yang, T. (2013) · Endocrine · doi:10.1007/s12020-013-0030-z · Cited by 27
Stem-Cell-like Qualities of Immune Memory; CD4+ T Cells Join the Party
Luckey, C. J., & Weaver, C. T. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.01.011 · Cited by 26
Munegowda, M. A., Xu, S., Freywald, A., & Xiang, J. (2012) · Molecular Immunology · doi:10.1016/j.molimm.2012.02.120 · Cited by 21
Paulos, C. M., Wrzesinski, C., Kaiser, A., Hinrichs, C. S., Chieppa, M., Cassard, L., Palmer, D. C., Boni, A., Muranski, P. J., Yu, Z., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32205c1 · Cited by 21
Self-citationAdoptive immunotherapy of cancer: Gene transfer of T cell specificity
Al-Khami, A. A., Mehrotra, S., & Nishimura, M. I. (2011) · Self/Nonself · doi:10.4161/self.2.2.15832 · Cited by 13
Self-citation[Do Th17 cells play an important role in the pathogenesis and prognosis of ovarian cancer?].
Winkler, I., Gogacz, M., & Rechberger, T. (2012) · PubMed · Cited by 9
ICOStomizing Immunotherapies with T H 17
Garaude, J., & Blander, J. M. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001722 · Cited by 6
Cited by
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
The hypoxic tumour microenvironment
Petrova, V., Annicchiarico-Petruzzelli, M., Melino, G., & Amelio, I. (2018) · Oncogenesis · doi:10.1038/s41389-017-0011-9 · Cited by 1,019
Prospects for combining targeted and conventional cancer therapy with immunotherapy
Gotwals, P., Cameron, S., Cipolletta, D., Cremasco, V., Crystal, A., Hewes, B., Mueller, B., Quaratino, S., Sabatos-Peyton, C., Petruzzelli, L., et al. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.17 · Cited by 953
The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
Labani-Motlagh, A., Ashja-Mahdavi, M., & Loskog, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00940 · Cited by 751
Metabolic Reprogramming of Immune Cells in Cancer Progression
Biswas, S. K. (2015) · Immunity · doi:10.1016/j.immuni.2015.09.001 · Cited by 721
Metadata
- Authors
- Bailey, S. R., Nelson, M. H., Himes, R. A., Li, Z., Mehrotra, S., & Paulos, C. M.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2014-06-17
- Volume
- 5
- Pages
- 276-276
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2128792706
- Cited by
- 334
- References
- 139
- FWCI
- 12.58
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.